Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study

Therapeutic drug monitoring (TDM) of gentamicin in neonates is recommended for safe and effective dosing and is currently performed by plasma sampling, which is an invasive and painful procedure. In this study, feasibility of a non‐invasive gentamicin TDM strategy using saliva was investigated.

[1]  J. Peham,et al.  Directed Transport of CRP Across In Vitro Models of the Blood-Saliva Barrier Strengthens the Feasibility of Salivary CRP as Biomarker for Neonatal Sepsis , 2021, Pharmaceutics.

[2]  Jie Xu,et al.  A Case Study Evaluating the Efficacy of an Ad Hoc Hospital Collection Device for Fentanyl in Infant Oral Fluid. , 2020, Journal of analytical toxicology.

[3]  S. Wicha,et al.  Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review. , 2020, Frontiers in Pharmacology.

[4]  Arthur Christopoulos,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets , 2019, British journal of pharmacology.

[5]  Marlene Sinclair,et al.  A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants , 2018, British journal of clinical pharmacology.

[6]  C. Csajka,et al.  Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations , 2018, Antimicrobial Agents and Chemotherapy.

[7]  D. Touw,et al.  Lack of penetration of amikacin into saliva of tuberculosis patients , 2018, European Respiratory Journal.

[8]  T. D. de Haan,et al.  Population Pharmacokinetics and Dosing 1 Considerations for Gentamicin in Newborns with 2 Suspected or Proven Gram Negative Sepsis , 2016 .

[9]  T. Heeren,et al.  Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy. , 2016, British journal of clinical pharmacology.

[10]  F. Groenendaal,et al.  Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia. , 2016, British journal of clinical pharmacology.

[11]  T. Buclin,et al.  Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates. , 2014, British journal of clinical pharmacology.

[12]  H. Davies,et al.  Early-Onset Neonatal Sepsis , 2014, Clinical Microbiology Reviews.

[13]  P. Patsalos,et al.  Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva , 2013, Therapeutic drug monitoring.

[14]  Mats O. Karlsson,et al.  Standard Error of Empirical Bayes Estimate in NONMEM® VI , 2012, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[15]  M. Karlsson,et al.  Rapid Sample Size Calculations for a Defined Likelihood Ratio Test-Based Power in Mixed-Effects Models , 2012, The AAPS Journal.

[16]  M Laird Forrest,et al.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development. , 2011, Therapeutic delivery.

[17]  Paul H C Eilers,et al.  New Dutch reference curves for birthweight by gestational age. , 2009, Early human development.

[18]  R. Savic,et al.  Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions , 2009, The AAPS Journal.

[19]  J. Widness.  Pathophysiology of Anemia During the Neonatal Period, Including Anemia of Prematurity. , 2008, NeoReviews.

[20]  J. Davies,et al.  Measurement of tobramycin and gentamicin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[21]  K. Coulthard,et al.  Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[22]  Stuart L. Beal,et al.  Ways to Fit a PK Model with Some Data Below the Quantification Limit , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[23]  M. Berkovitch,et al.  Therapeutic drug monitoring of once daily gentamicin in serum and saliva of children , 2000, European Journal of Pediatrics.

[24]  S. Choe,et al.  Intestinal Transport of Gentamicin with a Novel, Glycosteroid Drug Transport Agent , 1998, Pharmaceutical Research.

[25]  E. Williams,et al.  Algorithm to control "effect compartment" drug concentrations in pharmacokinetic model-driven drug delivery , 1993, IEEE Transactions on Biomedical Engineering.

[26]  W. Jusko,et al.  Pharmacokinetic Principles of Drug Distribution in Saliva a , 1993, Annals of the New York Academy of Sciences.

[27]  L. Brion,et al.  Gentamicin interval in newborn infants as determined by renal function and postconceptional age , 1991, Pediatric Nephrology.

[28]  Marc R. Gastonguay,et al.  Simulation from ODE-based population PK/PD and systems pharmacology models in R with mrgsolve , 2015 .

[29]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[30]  M. Shimono,et al.  Intercellular junctions in developing rat submandibular glands. (I) Tight junctions. , 1981, Journal of electron microscopy.